Question explored with the scientific record
will the prostate grow faster after a prostatectomy
The prostate does not "grow faster" after a prostatectomy. The question conflates regrowth of benign tissue with the recurrence of cancer, and the evidence here is almost entirely about the latter.
The retrieved studies overwhelmingly focus on residual or recurrent prostate cancer after radical prostatectomy, not on regrowth of benign prostatic hyperplasia (BPH) tissue. One 1988 study found residual tumor in 86% of radical prostatectomy specimens, mostly at the apex or anteriorly [1]. This is leftover cancer, not new growth. A 2009 study showed that after surgery for BPH (TURP, HoLRP, or open prostatectomy), PSA levels drop sharply and then stay low or stable, indicating the bulk of benign tissue is gone and does not rapidly return [3]. The 2015 study of robot-assisted radical prostatectomy found durable improvements in urinary flow lasting over five years, which would not happen if the prostate were regrowing quickly [2].
What the evidence does show is that cancer recurrence is a real risk, driven by the aggressiveness of the original tumor, not by the surgery itself. A 2006 study found that lymph node involvement and Gleason grade predicted a shorter PSA doubling time after recurrence [4]. A 2005 nomogram predicted a 10-year recurrence probability of about 21% in a modeling set [5]. The 2016 randomized trial found no difference in early urinary or sexual function between open and robotic surgery, but positive surgical margins occurred in 10-15% of cases, which is a risk factor for later recurrence [6].
My call: The prostate does not grow back faster after a prostatectomy. The risk is that residual cancer cells, left behind at surgery, can grow into a detectable recurrence. The speed of that recurrence depends on the tumor's biology, not on the surgery itself. Confidence: high for the core question; the evidence base is strong that benign regrowth is not the issue.
Sources used 6
-
The Volume and Anatomical Location of Residual Tumor in Radical Prostatectomy Specimens Removed for Stage A1 Prostate Cancer
Histological analysis of 21 radical retropubic prostatectomy specimens from men with clinically occult stage Al prostate cancer found residual tumor in 18 (86%), with most residual tumor located apically or anteriorly, and concluded that radical prostatectomy remains a reasonabl…
DOI: 10.1016/s0022-5347(17)42735-2 -
Analysis of Improved Urinary Peak Flow Rates After Robot-Assisted Radical Prostatectomy
This prospective, single-surgeon study analyzes pre- and post-operative urinary uroflowmetry in 550 men undergoing robot-assisted radical prostatectomy (RARP) to show durable, multi-year improvements in peak urinary flow rate (PFR) and reductions in postvoid residual (PVR) acros…
DOI: 10.1089/end.2015.0353 -
Postoperative PSA and PSA Velocity Identify Presence of Prostate Cancer After Various Surgical Interventions for Benign Prostatic Hyperplasia
This study investigates the ability of postoperative prostate-specific antigen (PSA) levels and PSA velocity to differentiate between patients with prostate cancer and those with benign prostatic hyperplasia after various surgical interventions.
DOI: 10.1016/j.urology.2008.10.062 -
Characterization of Biochemical Recurrence after Radical Prostatectomy
In 64 men with biochemical recurrence after radical prostatectomy, lymph node involvement and Gleason grade predicted shorter PSA doubling time, while Gleason grade and pathologic stage predicted time to recurrence; PSADT and recurrence time did not correlate.
DOI: 10.1159/000093906 -
Postoperative Nomogram Predicting the 10-Year Probability of Prostate Cancer Recurrence After Radical Prostatectomy
This study presents an updated postoperative nomogram that predicts the 10-year probability of prostate cancer recurrence after radical prostatectomy, incorporating adjustments for disease-free intervals and validated across multiple patient cohorts.
DOI: 10.1200/jco.2005.01.867 -
Robot-assisted laparoscopic prostatectomy versus open radical retropubic prostatectomy: early outcomes from a randomised controlled phase 3 study
This randomized controlled phase 3 study compares early postoperative outcomes of robot-assisted laparoscopic prostatectomy and open radical retropubic prostatectomy in men with localized prostate cancer, finding no significant differences in urinary and sexual function at 12 we…
DOI: 10.1016/S0140-6736(16)30592-X